Fund Holdings — BML Capital Management, LLC

Total Portfolio Value:
$123.56M
Total Bought:
$28.37M
Total Sold:
$35.21M
Net Transaction:
-$6.83M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Atea Pharmaceuticals, Inc.(AVIR)7,608,3127,609,812+1,500$25.49M$22.75M18.41%-$2.73M
Aclaris Therapeutics, Inc.(ACRS)14,250,00014,250,0000$35.34M$21.80M17.65%-$13.54M
Third Harmonic Bio Inc03,824,417+3,824,417$0$13.27M10.74%+$13.27M
Adverum Biotechnologies Inc2,268,0642,742,317+474,253$10.59M$11.98M9.70%+$1.39M
An2 Therapeutics Inc5,749,4325,749,4320$7.93M$7.82M6.33%-$115.0K
Instil Bio, Inc.(TIL)400,000416,720+16,720$7.64M$7.23M5.85%-$401.7K
Essa Pharma Inc4,221,5464,221,5460$7.56M$6.67M5.40%-$886.5K
Oramed Pharmaceuticals Inc.(ORMP)2,643,9073,020,748+376,841$6.40M$6.46M5.23%+$66.1K
Ikena Oncology Inc3,585,8663,710,803+124,937$5.88M$4.75M3.84%-$1.13M
PMV Pharmaceuticals, Inc.(PMVP)3,466,6843,747,612+280,928$5.23M$4.08M3.31%-$1.15M
Whitehawk Therapeutics, Inc.(WHWK)2,100,0001,890,245-209,755$6.63M$3.36M2.72%-$3.26M
Lava Therapeutics NvSHS01,960,610+1,960,610$0$2.49M2.02%+$2.49M
Kezar Life Sciences Inc
COM NEW
48,668408,138+359,470$327.0K$1.99M1.61%+$1.66M
Elevation Oncology Inc05,890,934+5,890,934$0$1.53M1.24%+$1.53M
Astrotech Corp220,410220,4100$1.48M$1.43M1.16%-$52.9K
Connect Biopharma Hldgs LtdADS2,093,2322,093,2320$2.89M$1.15M0.93%-$1.74M
Sage Therapeutics Inc0135,095+135,095$0$1.07M0.87%+$1.07M
Athira Pharma Inc2,775,8853,200,667+424,782$1.63M$911.9K0.74%-$716.7K
Milestone Pharmaceuticals Inc.(MIST)1,136,0911,136,0910$2.68M$909.0K0.74%-$1.77M
Lisata Therapeutics, Inc.(LSTA)284,669216,853-67,816$848.3K$509.6K0.41%-$338.7K
Turnstone Biologics Corp01,103,386+1,103,386$0$452.4K0.37%+$452.4K
Vistagen Therapeutics, Inc.(VTGN)150,000150,0000$442.5K$375.0K0.30%-$67.5K
Alumis Inc049,627+49,627$0$304.7K0.25%+$304.7K
Nextcure Inc273,536273,5360$210.9K$131.4K0.11%-$79.5K
Verrica Pharmaceuticals Inc.(VRCA)174,651174,6510$122.3K$77.2K0.06%-$45.0K
Hillevax Inc20,76020,7600$43.0K$30.1K0.02%-$12.9K
Achilles Therapeutics PlcADS4,100,0023,804,921-295,081$4.67M$0—-$4.67M
Allovir Inc184,2460-184,246$77.4K$0—-$77.4K
Ishares Tr0 3 MNTH TREASRY
0-3 MTH TREASURY
260,0000-260,000$26.08M$0—-$26.08M
LENZ Therapeutics, Inc.(LENZ)9,2710-9,271$267.7K$0—-$267.7K
Palvella Therapeutics, Inc.(PVLA)42,1300-42,130$505.6K$0—-$505.6K
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q1 2025 | TickerTrail